BOC-4-氨基苄醇 | 144072-29-7

• 物质功能分类: 生物化工 - 生化试剂 - 氨基酸
• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: BOC-4-氨基苄醇
• 中文别名: 4-(Boc-氨基)苯甲醇
• 英文名称: tert-butyl N-[4-(hydroxymethyl)phenyl]carbamate
• 英文别名: tert-butyl (4-(hydroxymethyl)phenyl)carbamate；4-(tert-butoxycarbonylamino)benzyl alcohol；4-[N-(tert-butoxycarbonyl)amino]benzyl alcohol
• CAS: 144072-29-7
• 化学式: C₁₂H₁₇NO₃
• 分子量: 223.272
• InChiKey: YQKDTZYYROHLMB-UHFFFAOYSA-N

物化性质

• 熔点：
  74-76 °C
• 沸点：
  310.0±25.0 °C(Predicted)
• 密度：
  1.161±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  58.6
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 海关编码：
  2924299090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335
• 储存条件：
  室温且干燥

反应信息

• 作为反应物：
  描述：

  BOC-4-氨基苄醇 在 盐酸 、 sodium azide 、 四丁基溴化铵 、 三苯基膦 作用下， 以 四氢呋喃 、 水 、 丙酮 为溶剂， 反应 6.5h， 生成 4-(Boc-氨基)苄胺
  参考文献：
  名称：

  Discovery of 1,2,4-thiadiazolidine-3,5-dione analogs that exhibit unusual and selective rapid cell death kinetics against acute myelogenous leukemia cells in culture

  摘要：

  4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD-8) was previously identified as an antileukemic agent exhibiting no evident toxicity toward normal hematopoietic cells. An SAR study has been carried out to examine the effect of varying the C-2 and C-4- substituents on the thiadiazolidinone ring of TDZD-8 on antileukemic activity. These studies resulted in the identification of more druglike analogs that exhibited comparable potency to TDZD-8 in killing acute myelogenous leukemia (AML) cells in culture. Surprisingly, the cell death kinetics induced by several of these novel analogs on MV-411 cells were extremely fast, with commitment to death occurring within 30 min. At a concentration of 10 mu M, 3f (LD50 = 3.5 mu M) completely eradicated cell viability of MV-411 cells within 2 h, while analog 3e (LD50 = 2.0 mu M) decimated cell viability within 30 min at a concentration of 10 mu M and effectively abolished cell viability at 5 mu M within 1-2 h. (C) 2011 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2011.06.027
• 作为产物：
  描述：

  二碳酸二叔丁酯 在 二异丁基氢化铝 、 N,N-二异丙基乙胺 作用下， 以 甲苯 、 乙腈 为溶剂， 反应 98.0h， 生成 BOC-4-氨基苄醇
  参考文献：
  名称：

  Design and Synthesis of Non-peptidic Inhibitors for the Syk C-Terminal SH2 Domain Based on Structure-Based In-Silico Screening

  摘要：

  Structure-based in-silico screening was carried out for the Syk C-terminal SH2 domain. Fragments that could interact with the pY or pY+1 pockets were selected by our in-silico screening. After tethering two fragments bound to these pockets, we have designed and synthesized new compounds that show favorable interaction with the pY+3 pocket. One such compound, having a cyclohexylmalonic acid moiety identified as a novel potent phosphotyrosyl mimetic, exhibited an affinity comparable to that of the monophosphorylated ligand peptide.

  DOI：

  10.1021/jm010313k

文献信息

• PROKINETICIN 1 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN
  申请人：Flores Christopher M.

  公开号：US20110319418A1

  公开（公告）日：2011-12-29

  Disclosed are compounds, compositions and methods for treating pain, including inflammatory, visceral, and acute pain. Such compounds are represented by Formula (I) as follows: wherein A 1 , L 1 , D, L 2 , and Q are defined herein.

  揭示了用于治疗疼痛的化合物、组合物和方法，包括炎症性、内脏性和急性疼痛。这些化合物由以下式（I）表示： 其中A1、L1、D、L2和Q在此处定义。
• [EN] DRUG-LINKER CONJUGATE PHARMACEUTICAL COMPOSITIONS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES DE CONJUGUÉ MÉDICAMENT-LIEUR
  申请人：UNIV BAYLOR

  公开号：WO2017066668A1

  公开（公告）日：2017-04-20

  Compositions are disclosed having a cytotoxic and/or vascular disrupting agent (VDA) payload attached to a linker. The linker can be a cathepsin B protease cleavable linker or a non-cleavable linker that may degrade intracellularly. Methods for making and using the compositions are also provided. The compositions can be provided to a patient in need thereof with the composition coming into contact with a cancer cell to activate or release the cytotoxic and/or vascular disrupting agent payload.

  披露了具有细胞毒性和/或血管破坏剂（VDA）有效载荷与连接剂连接的组成物。连接剂可以是组织蛋白酶B蛋白水解酶可切割连接剂，也可以是在细胞内降解的非切割连接剂。还提供了制造和使用该组成物的方法。可以将该组成物提供给需要的患者，使该组成物与癌细胞接触，以激活或释放细胞毒性和/或血管破坏剂有效载荷。
• Simple and Efficient Ruthenium-Catalyzed Oxidation of Primary Alcohols with Molecular Oxygen
  作者：Ritwika Ray、Shubhadeep Chandra、Debabrata Maiti、Goutam Kumar Lahiri

  DOI：10.1002/chem.201601800

  日期：2016.6.20

  oxidation of a wide variety of primary, as well as secondary benzylic, allylic, heterocyclic, and aliphatic, alcohols with molecular oxygen as the primary oxidant and without any base or hydrogen‐ or electron‐transfer agents. Most importantly, a high degree of selectivity during alcohol oxidation has been predicted for complex settings. Preliminary mechanistic studies including 18O labeling established

  从生态和经济的角度来看，利用分子氧（O 2）作为化学计量的氧化剂的氧化转化在有机合成中至关重要。采用O 2的醇氧化反应在均相催化中是稀缺的，并且此类系统的功效受到受限的底物范围（最涉及仲醇氧化）或实际因素（例如，需要过量的碱或添加剂）的限制。使用O 2的催化系统在没有任何添加剂的情况下，作为“主要”氧化剂的情况很少见。通过开发有效的钌催化氧化方案，可以解决这一长期存在的问题，该方案可以平滑氧化多种分子氧为分子的伯醇和仲醇，仲醇，烯丙基，杂环和脂肪族醇。主要氧化剂，无任何碱或氢或电子转移剂。最重要的是，对于复杂的环境，已经预测了醇氧化过程中的高度选择性。包括18 O标记在内的初步机理研究确定了原位形成氧-钌中间体作为循环中的活性催化物质，并在限速步骤中涉及了两个电子氢化物的转移。
• Efficient and expeditious chemoselective BOC protection of amines in catalyst and solvent-free media
  作者：Balaga Viswanadham、Abdul S. Mahomed、Holger B. Friedrich、Sooboo Singh

  DOI：10.1007/s11164-016-2702-9

  日期：2017.3

  A green and eco-friendly route for the almost quantitative BOC protection of a large variety of aliphatic and aromatic amines, amino acids, and amino alcohols is reported in catalyst and solvent-free media under mild reaction conditions. The products were confirmed by 1H, 13C NMR, IR spectroscopy, and in some cases, elemental analysis. This protocol does not require any water quenches, solvent separations

  据报道，在温和的反应条件下，在无催化剂和无溶剂的介质中，绿色环保的路线几乎可以定量保护各种脂肪族和芳香族胺，氨基酸和氨基醇的BOC。产物通过1 H，13 C NMR，IR光谱和某些情况下的元素分析确认。该方案不需要任何水淬，溶剂分离和纯化步骤，例如重结晶和柱色谱法。
• Synthesis of Nitrogen‐Containing Goniothalamin Analogues with Higher Cytotoxic Activity and Selectivity against Cancer Cells
  作者：Matheus A. Meirelles、Carolyne B. Braga、Catia Ornelas、Ronaldo A. Pilli

  DOI：10.1002/cmdc.201900281

  日期：2019.8.6

  goniothalamin analogues displaying nitrogen‐containing groups were designed and synthesized. A total of 19 novel analogues were evaluated against a panel of four different cancer cell lines, along with the normal prostate cell line PNT2 to determine their selectivity. Among them, goniothalamin chloroacrylamide 13 e displayed the lowest IC50 values for both MCF‐7 (0.5 μm) and PC3 (0.3 μm) cells, about 26‐fold

  设计并合成了两个显示出含氮基团的外消旋Goniothalamin类似物系列。针对四种不同癌细胞系以及正常前列腺细胞系PNT2评估了总共19种新的类似物，以确定它们的选择性。其中，goniothalamin氯丙烯酰胺13e中所显示的最低IC 50两者MCF-7（0.5μ值米）和PC3（0.3μ米）细胞，约26倍goniothalamin（更有效1）。除了具有更高的效力外，化合物13 e还显示出比Goniothalamin高得多的选择性。相比之下，Goniothalamin异丁酰胺13 c反对Caco-2细胞的最有效的类似物（IC 50 = 0.8μ米），约10倍更有效和17倍的选择性1。这些结果揭示化合物的潜在13c中和13e的用于进一步的体内研究，表示与IC第一goniothalamin类似物50个在针对MCF-7，将Caco-2低微摩尔范围和高选择性值，和PC3肿瘤细胞系。